Valiant Organics Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹218Cr
- +6.9% YoY
- +37.1% QoQ
- Net profit
- ₹16Cr
- +300% YoY
- +300% QoQ
- Margin
- 12%
- +2 pp YoY
- +4 pp QoQ
Top 10 Chemicals & Petrochemicals companies on management guidance
See the sector's top 10 — free with your mobile number.
Based on Valiant Organics Ltd's Q4 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q4-FY26 Consolidated Revenue from Operations: INR 2,178 million, up 6.9% year-on-year from INR 2,038 million in Q4-FY25 (Page 12). Quarterly Q4-FY26 (Standalone) Financials: - EBITDA: INR 265 Mn (↑ 30.5% YoY from INR 203 Mn) - EBITDA Margin: 12.17% (↑ 221 bps YoY from 9.96%) - Profit After Tax (PAT): INR 151 Mn (↑ signifi
From Valiant Organics Ltd's Q4 FY26 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q4-FY26 Consolidated Revenue from Operations: INR 2,178 million, up 6.9% year-on-year from INR 2,038 million in Q4-FY25 (Page 12).
- Q4-FY26 Standalone Revenue from Operations: INR 2,177 million, up 6.8% year-on-year from INR 2,038 million in Q4-FY25 (Page 14).
- Sales Volumes by Chemistry (Q4-FY26 vs. Q4-FY25):
- Chlorination: approx. 413 MT vs. 362 MT
- Hydrogenation: approx. 1,050 MT vs. 672 MT
2 more points from Valiant Organics Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Valiant Organics Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
2 more points from Valiant Organics Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Valiant Organics Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Valiant Organics Ltd said on order book & pipeline — free account, 30 seconds.
Valiant Organics Ltd — Quarterly revenue & net profit
Valiant Organics Ltd Q4 FY26 results — key figures
| ₹ Cr | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 218 | 204 | +6.9% | 159 | +37.1% |
| Operating profit (EBITDA) | 26 | 21 | +23.8% | 13 | +100% |
| Operating margin | 12% | 10% | +2 pp | 8% | +4 pp |
| Profit before tax | 18 | 7 | +157.1% | 6 | +200% |
| Net profit (PAT) | 16 | 4 | +300% | 4 | +300% |
| EPS (₹) | 5.61 | 1.50 | +274% | 1.30 | +331.5% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹304 Cr, net profit ₹17 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Valiant Organics's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Indian Phosphate (Q4 FY26)
H2 FY26 Revenue (Consolidated):** ₹580.25 Cr, up from ₹451.59 Cr in H2 FY25 — a year-on-year increase of ₹128.66 Cr. Key investor presentation takeaways from In
- Paragon Fine (Q4 FY26)
Revenue for H2FY26:** Rs 68.88 Cr, up 7.41% YoY from Rs 64.13 Cr in H2FY25 (Page 22). Key investor presentation takeaways from Paragon Fine's Q4 FY26 investor p
- IVP (Q4 FY26)
Q4 FY26 revenue from operations: ₹164.44 crore . Key investor presentation takeaways from IVP's Q4 FY26 investor presentation — and how it ranks against sector
- Vishnu Chemicals (Q4 FY26)
Q4 FY26 Operating Revenues: ₹450.3 crore, up 14.7% YoY from ₹392.6 crore in Q4 FY25 (Page 5). Key investor presentation takeaways from Vishnu Chemicals Ltd's Q4
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Valiant Organics Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Valiant Organics Ltd Q4 FY26 results?
Q4-FY26 Consolidated Revenue from Operations: INR 2,178 million, up 6.9% year-on-year from INR 2,038 million in Q4-FY25 (Page 12). Quarterly Q4-FY26 (Standalone) Financials: - EBITDA: INR 265 Mn (↑ 30.5% YoY from INR 203 Mn) - EBITDA Margin: 12.17% (↑ 221 bps YoY from 9.96%) - Profit After Tax (PAT): INR 151 Mn (↑ signifi
What is Valiant Organics Ltd share price analysis?
Valiant Organics Ltd currently shows a neutral. The stock trades at a P/E of 23.7 with a market cap of ₹1,196 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Valiant Organics Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
